236 related articles for article (PubMed ID: 32308020)
1. Genetic ablation of SLK exacerbates glomerular injury in adriamycin nephrosis in mice.
Woychyshyn B; Papillon J; Guillemette J; Navarro-Betancourt JR; Cybulsky AV
Am J Physiol Renal Physiol; 2020 Jun; 318(6):F1377-F1390. PubMed ID: 32308020
[TBL] [Abstract][Full Text] [Related]
2. Ste20-like kinase, SLK, a novel mediator of podocyte integrity.
Cybulsky AV; Papillon J; Guillemette J; Belkina N; Patino-Lopez G; Torban E
Am J Physiol Renal Physiol; 2018 Jul; 315(1):F186-F198. PubMed ID: 29187370
[TBL] [Abstract][Full Text] [Related]
3. Role of the Ste20-like kinase SLK in podocyte adhesion.
Cybulsky AV; Papillon J; Bryan C; Navarro-Betancourt JR; Sabourin LA
Physiol Rep; 2024 Jan; 12(1):e15897. PubMed ID: 38163671
[TBL] [Abstract][Full Text] [Related]
4. Podocyte injury and albuminuria in mice with podocyte-specific overexpression of the Ste20-like kinase, SLK.
Cybulsky AV; Takano T; Papillon J; Guillemette J; Herzenberg AM; Kennedy CR
Am J Pathol; 2010 Nov; 177(5):2290-9. PubMed ID: 20889563
[TBL] [Abstract][Full Text] [Related]
5. CLIC5A, a component of the ezrin-podocalyxin complex in glomeruli, is a determinant of podocyte integrity.
Wegner B; Al-Momany A; Kulak SC; Kozlowski K; Obeidat M; Jahroudi N; Paes J; Berryman M; Ballermann BJ
Am J Physiol Renal Physiol; 2010 Jun; 298(6):F1492-503. PubMed ID: 20335315
[TBL] [Abstract][Full Text] [Related]
6. Genetic Ablation of Calcium-independent Phospholipase A
Elimam H; Papillon J; Guillemette J; Navarro-Betancourt JR; Cybulsky AV
Sci Rep; 2019 Nov; 9(1):16229. PubMed ID: 31700134
[TBL] [Abstract][Full Text] [Related]
7. Active proteases in nephrotic plasma lead to a podocin-dependent phosphorylation of VASP in podocytes via protease activated receptor-1.
Harris JJ; McCarthy HJ; Ni L; Wherlock M; Kang H; Wetzels JF; Welsh GI; Saleem MA
J Pathol; 2013 Apr; 229(5):660-71. PubMed ID: 23436459
[TBL] [Abstract][Full Text] [Related]
8. Cyclic AMP prevents decrease of phosphorylated ezrin/radixin/moesin and chloride intracellular channel 5 expressions in injured podocytes.
Tao H; Li X; Wei K; Xie K; Ni Z; Gu L
Clin Exp Nephrol; 2015 Dec; 19(6):1000-6. PubMed ID: 25725994
[TBL] [Abstract][Full Text] [Related]
9. Connective tissue growth factor modulates podocyte actin cytoskeleton and extracellular matrix synthesis and is induced in podocytes upon injury.
Fuchshofer R; Ullmann S; Zeilbeck LF; Baumann M; Junglas B; Tamm ER
Histochem Cell Biol; 2011 Sep; 136(3):301-19. PubMed ID: 21814837
[TBL] [Abstract][Full Text] [Related]
10. Rac1 in podocytes promotes glomerular repair and limits the formation of sclerosis.
Asao R; Seki T; Takagi M; Yamada H; Kodama F; Hosoe-Nagai Y; Tanaka E; Trejo JAO; Yamamoto-Nonaka K; Sasaki Y; Hidaka T; Ueno T; Yanagita M; Suzuki Y; Tomino Y; Asanuma K
Sci Rep; 2018 Mar; 8(1):5061. PubMed ID: 29567961
[TBL] [Abstract][Full Text] [Related]
11. The Hippo pathway regulator KIBRA promotes podocyte injury by inhibiting YAP signaling and disrupting actin cytoskeletal dynamics.
Meliambro K; Wong JS; Ray J; Calizo RC; Towne S; Cole B; El Salem F; Gordon RE; Kaufman L; He JC; Azeloglu EU; Campbell KN
J Biol Chem; 2017 Dec; 292(51):21137-21148. PubMed ID: 28982981
[TBL] [Abstract][Full Text] [Related]
12. Activated ERK1/2 increases CD44 in glomerular parietal epithelial cells leading to matrix expansion.
Roeder SS; Barnes TJ; Lee JS; Kato I; Eng DG; Kaverina NV; Sunseri MW; Daniel C; Amann K; Pippin JW; Shankland SJ
Kidney Int; 2017 Apr; 91(4):896-913. PubMed ID: 27998643
[TBL] [Abstract][Full Text] [Related]
13. Re-expression of Sall1 in podocytes protects against adriamycin-induced nephrosis.
Hosoe-Nagai Y; Hidaka T; Sonoda A; Sasaki Y; Yamamoto-Nonaka K; Seki T; Asao R; Tanaka E; Trejo JAO; Kodama F; Takagi M; Tada N; Ueno T; Nishinakamura R; Tomino Y; Asanuma K
Lab Invest; 2017 Nov; 97(11):1306-1320. PubMed ID: 28759006
[TBL] [Abstract][Full Text] [Related]
14. Nephrin-Ephrin-B1-Na
Fukusumi Y; Yasuda H; Zhang Y; Kawachi H
Am J Pathol; 2021 Jul; 191(7):1209-1226. PubMed ID: 33887216
[TBL] [Abstract][Full Text] [Related]
15. Fibrinogen links podocyte injury with Toll-like receptor 4 and is associated with disease activity in FSGS patients.
Wang H; Zheng C; Xu X; Zhao Y; Lu Y; Liu Z
Nephrology (Carlton); 2018 May; 23(5):418-429. PubMed ID: 28407405
[TBL] [Abstract][Full Text] [Related]
16. BDNF repairs podocyte damage by microRNA-mediated increase of actin polymerization.
Li M; Armelloni S; Zennaro C; Wei C; Corbelli A; Ikehata M; Berra S; Giardino L; Mattinzoli D; Watanabe S; Agostoni C; Edefonti A; Reiser J; Messa P; Rastaldi MP
J Pathol; 2015 Apr; 235(5):731-44. PubMed ID: 25408545
[TBL] [Abstract][Full Text] [Related]
17. Melanocortin therapy ameliorates podocytopathy and proteinuria in experimental focal segmental glomerulosclerosis involving a podocyte specific non-MC1R-mediated melanocortinergic signaling.
Qiao Y; Wang P; Chang M; Chen B; Ge Y; Malhotra DK; Dworkin LD; Gong R
Clin Sci (Lond); 2020 Apr; 134(7):695-710. PubMed ID: 32167144
[TBL] [Abstract][Full Text] [Related]
18. Asparagine endopeptidase protects podocytes in adriamycin-induced nephropathy by regulating actin dynamics through cleaving transgelin.
Qiu Y; Lei C; Zeng J; Xie Y; Cao Y; Yuan Q; Su H; Zhang Z; Zhang C
Mol Ther; 2023 Nov; 31(11):3337-3354. PubMed ID: 37689970
[TBL] [Abstract][Full Text] [Related]
19. AMPK mediates regulation of glomerular volume and podocyte survival.
Banu K; Lin Q; Basgen JM; Planoutene M; Wei C; Reghuvaran AC; Tian X; Shi H; Garzon F; Garzia A; Chun N; Cumpelik A; Santeusanio AD; Zhang W; Das B; Salem F; Li L; Ishibe S; Cantley LG; Kaufman L; Lemley KV; Ni Z; He JC; Murphy B; Menon MC
JCI Insight; 2021 Oct; 6(19):. PubMed ID: 34473647
[TBL] [Abstract][Full Text] [Related]
20. Loss of ezrin expression reduced the susceptibility to the glomerular injury in mice.
Hatano R; Takeda A; Abe Y; Kawaguchi K; Kazama I; Matsubara M; Asano S
Sci Rep; 2018 Mar; 8(1):4512. PubMed ID: 29540766
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
